Five new rifamycin derivatives, named salinirifamycins A-E (1-5), were isolated from a Brazilian marine Salinispora arenicola (BRA-213) strain extract. The structures of the new rifamycins were elucidated using a combination of NMR, IR, UV, and MS spectroscopic techniques, quantum-chemical calculations (DFT-calculated 13C NMR chemical shifts and DP4+ probability analysis), and comparison of experimental and calculated electronic circular dichroism (ECD) spectra. Compounds 1, 2, and 4 displayed antibacterial activity against Staphylococcus aureus and Enterococcus faecalis with MIC values ranging from 2.0 to 125.0 μg/mL, whereas 5 exhibited an MIC of 0.02 μg/mL to S. aureus, similar to the positive control rifampicin (MIC 0.03 μg/mL).

Salinirifamycins A–E: Rifamycin S Derivatives from the Brazilian Marine Actinomycete Salinispora arenicola / Batista Da Silva, Alison; Pinto, Francisco Chagas L.; Silveira, Edilberto R.; Paulo, Tercio De Freitas; Wilke, Diego V.; Ferreira, Elthon G.; Costa-Lotufo, Leticia V.; Canuto, Kirley M.; Marinho-Filho, José Delano Barreto; Barros, Ayslan B.; Nuzzo, Genoveffa; Fontana, Angelo; Monteiro, Norberto Kássio. V.; Pessoa, Otilia D. L.. - In: JOURNAL OF NATURAL PRODUCTS. - ISSN 0163-3864. - 89:1(2026), pp. 304-312. [10.1021/acs.jnatprod.5c01381]

Salinirifamycins A–E: Rifamycin S Derivatives from the Brazilian Marine Actinomycete Salinispora arenicola

Fontana, Angelo;
2026

Abstract

Five new rifamycin derivatives, named salinirifamycins A-E (1-5), were isolated from a Brazilian marine Salinispora arenicola (BRA-213) strain extract. The structures of the new rifamycins were elucidated using a combination of NMR, IR, UV, and MS spectroscopic techniques, quantum-chemical calculations (DFT-calculated 13C NMR chemical shifts and DP4+ probability analysis), and comparison of experimental and calculated electronic circular dichroism (ECD) spectra. Compounds 1, 2, and 4 displayed antibacterial activity against Staphylococcus aureus and Enterococcus faecalis with MIC values ranging from 2.0 to 125.0 μg/mL, whereas 5 exhibited an MIC of 0.02 μg/mL to S. aureus, similar to the positive control rifampicin (MIC 0.03 μg/mL).
2026
Salinirifamycins A–E: Rifamycin S Derivatives from the Brazilian Marine Actinomycete Salinispora arenicola / Batista Da Silva, Alison; Pinto, Francisco Chagas L.; Silveira, Edilberto R.; Paulo, Tercio De Freitas; Wilke, Diego V.; Ferreira, Elthon G.; Costa-Lotufo, Leticia V.; Canuto, Kirley M.; Marinho-Filho, José Delano Barreto; Barros, Ayslan B.; Nuzzo, Genoveffa; Fontana, Angelo; Monteiro, Norberto Kássio. V.; Pessoa, Otilia D. L.. - In: JOURNAL OF NATURAL PRODUCTS. - ISSN 0163-3864. - 89:1(2026), pp. 304-312. [10.1021/acs.jnatprod.5c01381]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/1048925
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact